Plasma Protein Therapeutics Association


The Plasma Protein Therapeutics Association (PPTA) is a key player in the plasma industry, collaborating with stakeholders and policymakers to establish standards and programs for donors and patients. The organization emphasizes the importance of plasma donation for treating rare and chronic diseases, and works to improve the safety, quality, and accessibility of plasma-derived medicines. PPTA advocates for access to therapies, advances understanding of the plasma ecosystem, and responsibly improves plasma availability through global standards, education, and collaboration. It actively engages in advocacy, education, and collaboration through various resources, videos, and podcasts to promote the value of plasma donation and therapies.

Industries

association
biotechnology
manufacturing

Nr. of Employees

small (1-50)

Plasma Protein Therapeutics Association

1620 Eye Street NW, Suite 850, Washington, D.C., 20006, USA


Products

The Source (industry magazine and publications)

Periodic magazine issues and published reports covering industry developments, policy, and technical topics related to plasma-derived therapies.

Patient Notification System and distribution data reports

Systems and reports for patient notification and product distribution data to support patient safety and supply-chain transparency.

Advocacy multimedia library and infographic pack

A downloadable and streamable collection of videos, webinars, podcasts, and printable infographics designed for public education and stakeholder advocacy, available in multiple languages and delivered via embedded third-party media hosting with analytics.


Services

Independent recognition program that evaluates adherence of plasma collection centers to established global industry standards.

Voluntary standards and guidance for the collection, processing, and testing of source plasma by fractionators.

Collections of downloadable advocacy toolkits, infographics, videos, webinars, and podcasts produced and localized for multiple languages to support outreach to donors, patients, clinicians, and policymakers. Includes embedded media delivered via third-party hosting and associated analytics/tracking for engagement measurement.

Planning and execution of international congresses and related meetings to convene clinicians, industry representatives, regulators, and patient groups for technical and policy discussion.

Ongoing legislative and regulatory briefings, crisis management assistance, and access to curated industry reports and subscriptions for member organizations.

Programs to collect and report distribution data for plasma-derived products and systems to support rapid patient notification and product tracing.

Expertise Areas

  • Regulatory policy and stakeholder engagement
  • Standards development and third-party recognition for plasma collection and fractionation
  • Quality systems and GMP advocacy for biologics manufacturing
  • Donor safety and deferral registry management
  • Show More (4)

Key Technologies

  • Embedded third-party video hosting and player integration
  • Podcast hosting and distribution platforms
  • HTML5 on-demand video publishing
  • Multilingual content localization workflows
  • Show More (5)

News & Updates

April 5, 2025 - April 9, 2025, San Diego, California

June 20, 2025 - June 21, 2025, Miami Beach, Florida

June 27, 2025, Atlanta, Georgia, United States

June 10, 2025, The Czech Registry is recognized as a positive step in donor safety.

June 2, 2025, Leadership appointment for European efforts.

May 26, 2025, Official statement regarding the EDQM Blood Guide.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.